The Evaporative Dry Eye Experts
Our mission is to provide physicians with an effective way to identify and address the primary root cause of dry eye disease.
Our technology principle (based on more than 25 years of clinical research and anatomical findings) enables ophthalmologists to treat the root cause of lipid deficient evaporative dry eye.
TearScience was founded in 2005 to develop diagnostic and treatment devices targeted at the root cause of the majority of dry eye cases. The company has filed over 65 patent applications covering all areas of its technology, products and market utilization, and is an FDA registered and ISO 13485 compliant medical device facility.
The TearScience LipiView and LipiFlow devices are cleared for marketing in the European Union, Canada, Australia, New Zealand, and the U.S.